Literature DB >> 22559761

Pre-coverage assessments of new hospital interventions on Austria: methodology and 3 years of experience.

Philipp Mad1, Sabine Geiger-Gritsch, Gerda Hinterreiter, Stefan Mathis-Edenhofer, Claudia Wild.   

Abstract

OBJECTIVES: A new decision-making process was set up by the Austrian Ministry of Health to regulate coverage of new proposed Extra Medical Services (EMS; German: Medizinische Einzel-Leistung [MEL]) in 2008. As part of the annual decision-making process an independent academic institution (LBI-HTA) is evaluating relevant evidence on these new technologies and provides HTAs, including evidence-based recommendations for decision makers.
METHODS: About ten EMS assessments are performed annually by the LBI-HTA simultaneously between January and March. Each peer-reviewed report consists of a systematic literature review and critical appraisal of evidence using the GRADE methodology. The generation of numerous reports of good quality standards within the short timeframe is achieved by a standardized workflow with predefined assignment of tasks for all participants.
RESULTS: In total, the LBI-HTA performed twenty-five EMS assessments on thirty-three different interventions in the last three years. Coverage was recommended with limitation for eleven (33%) interventions, and not recommended for twenty-two (66%) interventions. The federal health commission decided on acceptance or preliminary acceptance of coverage in seven (22%) cases, rejection in eighteen (55%) cases and changed the status to "subject to approval" in seven (24%) cases.
CONCLUSIONS: Pre-coverage assessment of new hospital interventions was implemented successfully in Austria. It has proved to be a useful tool to support decision makers with objective evidence when deciding whether or not to reimburse medical services.

Entities:  

Mesh:

Year:  2012        PMID: 22559761     DOI: 10.1017/S0266462312000025

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  3 in total

1.  Contrasting clinical evidence for market authorisation of cardio-vascular devices in Europe and the USA: a systematic analysis of 10 devices based on Austrian pre-reimbursement assessments.

Authors:  Claudia Wild; Judit Erdös; Ingrid Zechmeister
Journal:  BMC Cardiovasc Disord       Date:  2014-11-04       Impact factor: 2.298

2.  Pre-reimbursement: early assessment for coverage decisions.

Authors:  Nicole Grössmann; Sarah Wolf; Katharina Rosian; Claudia Wild
Journal:  Wien Med Wochenschr       Date:  2019-02-06

3.  Reimbursement decisions for medical services in Austria: an analysis of influencing factors for the hospital individual services catalogue between 2008 and 2020.

Authors:  Gregor Goetz; Dimitra Panteli; Reinhard Busse; Claudia Wild
Journal:  BMC Health Serv Res       Date:  2022-02-15       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.